Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17671693

Download in:

View as

General Info

PMID
17671693